The impact of bleeding history, von Willebrand factor and PFA-100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD-Reference-Cited by-同舟云学术

The impact of bleeding history, von Willebrand factor and PFA-100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD

Published:2010-08-25 Issue:3 Volume:151 Page:245-251
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Castaman Giancarlo,Tosetto Alberto,Goodeve Anne,Federici Augusto B.,Lethagen Stefan,Budde Ulrich,Batlle Javier,Meyer Dominique,Mazurier Claudine,Goudemand Jenny,Eikenboom Jeroen,Schneppenheim Reinhard,Ingerslev Jorgen,Habart David,Hill Frank,Peake Ian,Rodeghiero Francesco

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08333.x/fullpdf

Reference19 articles.

1. Von Willebrand’s disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment;Castaman;Haematologica,2003

2. Are the bleeding time and PFA-100 useful in the initial screening of patients with mucocutaneous bleedings of hereditary nature?;Cattaneo;Journal of Thrombosis and Haemostasis,2004

3. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease;Cattaneo;Thrombosis and Haemostasis,1999

4. Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study;Daly;Blood,2009

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy;Journal of the Neurological Sciences;2024-08

2. Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review;Seminars in Thrombosis and Hemostasis;2024-07-01

3. Challenges in Platelet Functions in HIV/AIDS Management;Infectious Diseases;2023-02-08

4. Laboratory characterization of obligate carriers of type 3 von Willebrand disease with a potential role for Platelet Function Analyzer (PFA‐200);International Journal of Laboratory Hematology;2022-01-05

5. Prevalence of bleeding symptoms among young adults in Saudi Arabia, a national survey;Medicine;2021-10-29